IL6 and stroke disorder: To our knowledge, this is the first evidence revealing that astrocytic IL-6 could skew the immune response to a Th2 bias in the ischemic hemisphere and thus contribute to post-stroke neuroangiogenesis and hyperforin-mediated promoting neuroangiogenesis effects.